Document:

Exhibit
10.133

 

SECURITIES
PURCHASE AGREEMENT

 

This
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 28, 2021, by and between CLEAN ENERGY TECHNOLOGIES,
INC., a Nevada corporation, with its address at 2990 Redhill Ave., Costa Mesa, California 92626 (the “Company”), and
GENEVA ROTH REMARK HOLDINGS INC., a New York corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021
(the “Buyer”).

 

WHEREAS:

 

A.
The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the
Securities Act of 1933, as amended (the “1933 Act”); and

 

B.
Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement, a promissory
note of the Company, in the form attached hereto as Exhibit A, in the aggregate principal amount of $142,720.00 (including $14,720.00
of Original Issue Discount) (the “Note”).

 

NOW
THEREFORE, the Company and the Buyer severally (and not jointly) hereby agree as follows:

 

1.
Purchase and Sale of the Securities.

 

a.
Purchase of the Securities. On the Closing Date (as defined below), the Company shall issue and sell to the Buyer and the Buyer
agrees to purchase from the Company the Securities as is set forth immediately below the Buyer’s name on the signature pages hereto.

 

b.
Form of Payment. On the Closing Date (as defined below), (i) the Buyer shall pay the purchase price for the Securities be issued
and sold to it at the Closing (as defined below) (the “Purchase Price”) by wire transfer of immediately available funds to
the Company, in accordance with the Company’s written wiring instructions, against delivery of the Securities, and (ii) the Company
shall deliver such duly executed Note on behalf of the Company against delivery of such Purchase Price.

 

c.
Closing Date. Subject to the satisfaction (or written waiver) of the conditions thereto set forth in Section 6 and Section 7 below,
the date and time of the issuance and sale of the Securities pursuant to this Agreement (the “Closing Date”) shall be 12:00
noon, Eastern Standard Time on or about September 29, 2021, or such other mutually agreed upon time. The closing of the transactions
contemplated by this Agreement (the “Closing”) shall occur on the Closing Date at such location as may be agreed to by the
parties.

 

    	 

    	 

    

 

2.
Buyer’s Representations and Warranties. The Buyer represents and warrants to the Company that:

 

a.
Investment Purpose. As of the date hereof, the Buyer is purchasing the Note and the shares of Common Stock issuable upon conversion
of or otherwise pursuant to the Note (such shares of Common Stock being collectively referred to herein as the “Conversion Shares”
and, collectively with the Note, the “Securities”) for its own account and not with a present view towards the public sale
or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act.

 

b.
Accredited Investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation
D (an “Accredited Investor”).

 

c.
Reliance on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying upon the truth
and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer to acquire the
Securities.

 

d.
Information. The Company has not disclosed to the Buyer any material nonpublic information and will not disclose such information
unless such information is disclosed to the public prior to or promptly following such disclosure to the Buyer.

 

e.
Legends. The Buyer understands that the Securities have not been registered under the 1933 Act; and may bear a restrictive legend
in substantially the following form:

 

“THE
SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR UNDER ANY STATE SECURITIES LAWS, AND MAY NOT BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED OR OTHERWISE TRANSFERRED UNLESS
(1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR (2)
THE ISSUER OF SUCH SECURITIES RECEIVES AN OPINION OF COUNSEL TO THE BUYER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE REASONABLY
ACCEPTABLE TO THE ISSUER’S TRANSFER AGENT, THAT SUCH SECURITIES MAY BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED OR OTHERWISE TRANSFERRED
WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS.”

 

    	2

    	 

    

 

The
legend set forth above shall be removed and the Company shall issue a certificate without such legend to the Buyer of any Security upon
which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for sale under
an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to an exemption from registration without
any restriction as to the number of securities as of a particular date that can then be immediately sold, or (b) such Buyer provides
the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions, to
the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which opinion shall be
accepted by the Company so that the sale or transfer is effected. The Buyer agrees to sell all Securities, including those represented
by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements, if any. In
the event that the Company does not reasonably accept the opinion of counsel that properly conforms to applicable securities laws provided
by the Buyer with respect to the transfer of any Securities pursuant to an exemption from registration, such as Rule 144, at the Deadline,
it will be considered an Event of Default pursuant to Section 3.2 of the Note.

 

f.
Authorization; Enforcement. This Agreement has been duly and validly authorized. This Agreement has been duly executed and delivered
on behalf of the Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in accordance with its
terms.

 

3.
Representations and Warranties of the Company. The Company represents and warrants to the Buyer that:

 

a.
Organization and Qualification. The Company and each of its Subsidiaries (as defined below), if any, is a corporation duly organized,
validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate
and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated
and conducted. “Subsidiaries” means any corporation or other organization, whether incorporated or unincorporated, in which
the Company owns, directly or indirectly, any equity or other ownership interest.

 

b.
Authorization; Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement,
the Note and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms
hereof and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation by it of the transactions
contemplated hereby and thereby (including without limitation, the issuance of the Note has been duly authorized by the Company’s
Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its shareholders is required, (iii)
this Agreement has been duly executed and delivered by the Company by its authorized representative, and such authorized representative
is the true and official representative with authority to sign this Agreement and the other documents executed in connection herewith
and bind the Company accordingly, and (iv) this Agreement constitutes, and upon execution and delivery by the Company of the Note, each
of such instruments will constitute, a legal, valid and binding obligation of the Company enforceable against the Company in accordance
with its terms.

 

c.
Capitalization. As of the date hereof, the authorized common stock of the Company consists of 2,000,000,000 authorized shares
of Common Stock, $0.001 par value per share, of which 922,792,698 shares are issued and outstanding. All of such outstanding shares of
capital stock are, or upon issuance will be, duly authorized, validly issued, fully paid and non-assessable.

 

    	3

    	 

    

 

d.
Issuance of Shares. The Securities are duly authorized and reserved for issuance in accordance with its respective terms, will
be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances with respect to the issue thereof
and shall not be subject to preemptive rights or other similar rights of shareholders of the Company and will not impose personal liability
upon the Buyer thereof.

 

e.
No Conflicts. The execution, delivery and performance of this Agreement, the Note by the Company and the consummation by the Company
of the transactions contemplated hereby and thereby will not (i) conflict with or result in a violation of any provision of the Certificate
of Incorporation or By-laws, or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or
an event which with notice or lapse of time or both could become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture, patent, patent license or instrument to which the Company or any of its Subsidiaries
is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities
laws and regulations and regulations of any self-regulatory organizations to which the Company or its securities are subject) applicable
to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected
(except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually
or in the aggregate, have a Material Adverse Effect). The businesses of the Company and its Subsidiaries, if any, are not being conducted,
and shall not be conducted so long as the Buyer owns any of the Securities, in violation of any law, ordinance or regulation of any governmental
entity. “Material Adverse Effect” means any material adverse effect on the business, operations, assets, financial condition
or prospects of the Company or its Subsidiaries, if any, taken as a whole, or on the transactions contemplated hereby or by the agreements
or instruments to be entered into in connection herewith.

 

f.
SEC Documents; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by it with the SEC pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “1934
Act”) (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements and schedules
thereto and documents (other than exhibits to such documents) incorporated by reference therein, being hereinafter referred to herein
as the “SEC Documents”). Upon written request the Company will deliver to the Buyer true and complete copies of the SEC Documents,
except for such exhibits and incorporated documents. As of their respective dates or if amended, as of the dates of the amendments, the
SEC Documents complied in all material respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated
thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue
statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading. None of the statements made in any such SEC Documents
is, or has been, required to be amended or updated under applicable law (except for such statements as have been amended or updated in
subsequent filings prior the date hereof). As of their respective dates or if amended, as of the dates of the amendments, the financial
statements of the Company included in the SEC Documents complied as to form in all material respects with applicable accounting requirements
and the published rules and regulations of the SEC with respect thereto. Such financial statements have been prepared in accordance with
United States generally accepted accounting principles, consistently applied, during the periods involved and fairly present in all material
respects the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated
results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end
audit adjustments). The Company is subject to the reporting requirements of the 1934 Act.

 

    	4

    	 

    

 

g.
Absence of Certain Changes. Since June 30, 2021, except as set forth in the SEC Documents, there has been no material adverse
change and no material adverse development in the assets, liabilities, business, properties, operations, financial condition, results
of operations, prospects or 1934 Act reporting status of the Company or any of its Subsidiaries.

 

h.
Absence of Litigation. Except as set forth in the SEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation
before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company
or any of its Subsidiaries, threatened against or affecting the Company or any of its Subsidiaries, or their officers or directors in
their capacity as such, that could have a Material Adverse Effect. The Company and its Subsidiaries are unaware of any facts or circumstances
which might give rise to any of the foregoing.

 

i.
No Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly
or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would require
registration under the 1933 Act of the issuance of the Securities to the Buyer. The issuance of the Securities to the Buyer will not
be integrated with any other issuance of the Company’s securities (past, current or future) for purposes of any shareholder approval
provisions applicable to the Company or its securities.

 

j.
No Brokers. The Company has taken no action which would give rise to any claim by any person for brokerage commissions, transaction
fees or similar payments relating to this Agreement or the transactions contemplated hereby.

 

k.
No Investment Company. The Company is not, and upon the issuance and sale of the Securities as contemplated by this Agreement
will not be an “investment company” required to be registered under the Investment Company Act of 1940 (an “Investment
Company”). The Company is not controlled by an Investment Company.

 

l.
Breach of Representations and Warranties by the Company. If the Company breaches any of the material representations or warranties
set forth in this Section 3 which is continuing after the applicable cure period as set forth in the Note, if any, and in addition to
any other remedies available to the Buyer pursuant to this Agreement, it will be considered an Event of default under Section 4.4 of
the Note.

 

    	5

    	 

    

 

4.
COVENANTS.

 

a.
Best Efforts. The Company shall use its reasonable commercial efforts to satisfy timely each of the conditions described in Section
7 of this Agreement.

 

b.
[intentionally omitted.]

 

c.
Use of Proceeds. The Company shall use the proceeds for general working capital purposes.

 

d.
Expenses. At the Closing, the Company’s obligation with respect to the transactions contemplated by this Agreement is to
reimburse Buyer’ expenses shall be $3,000.00 for Buyer’s legal fees and due diligence fee.

 

e.
Corporate Existence. So long as the Buyer beneficially owns any Note, the Company shall maintain its corporate existence and shall
not sell all or substantially all of the Company’s assets, except with the prior written consent of the Buyer.

 

f.
Breach of Covenants. If the Company breaches any of the material covenants set forth in this Section 4, and in addition to any
other remedies available to the Buyer pursuant to this Agreement which is continuing after the applicable cure period as set forth in
the Note, it will be considered an event of default under Section 4.4 of the Note.

 

g.
Failure to Comply with the 1934 Act. So long as the Buyer beneficially owns the Note, the Company shall comply with the reporting
requirements of the 1934 Act; and the Company shall continue to be subject to the reporting requirements of the 1934 Act.

 

h.
The Buyer is Not a “Dealer”. The Buyer and the Company hereby acknowledge and agree that the Buyer has not: (i) acted
as an underwriter; (ii) acted as a market maker or specialist; (iii) acted as “de facto” market maker; or (iv) conducted
any other professional market activities such as providing investment advice, extending credit and lending securities in connection;
and thus that the Buyer is not a “Dealer” as such term is defined in the 1934 Act.

 

    	6

    	 

    

 

5.
Transfer Agent Instructions. The Company shall issue irrevocable instructions to its transfer agent to issue certificates, registered
in the name of the Buyer or its nominee, for the shares underlying any conversion of the Note upon default of the Note (the “Conversion
Shares”) in such amounts as specified from time to time by the Buyer to the Company upon conversion of the Note in accordance with
the terms thereof (the “Irrevocable Transfer Agent Instructions”). In the event that the Company proposes to replace its
transfer agent, the Company shall provide, prior to the effective date of such replacement, a fully executed Irrevocable Transfer Agent
Instructions in a form as initially delivered pursuant to this Agreement (including but not limited to the provision to irrevocably reserve
shares of Common Stock in the Reserved Amount as such term is defined in the Note) signed by the successor transfer agent to Company
and the Company. Prior to registration of the Conversion Shares under the 1933 Act or the date on which the Conversion Shares may be
sold pursuant to an exemption from registration, all such certificates shall bear the restrictive legend specified in Section 2(e) of
this Agreement. The Company warrants that: (i) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this
Section 5, will be given by the Company to its transfer agent and that the Securities shall otherwise be freely transferable on the books
and records of the Company as and to the extent provided in this Agreement and the Note; (ii) it will not direct its transfer agent not
to transfer or delay, impair, and/or hinder its transfer agent in transferring (or issuing)(electronically or in certificated form) any
certificate for Conversion Shares to be issued to the Buyer upon conversion of or otherwise pursuant to the Note as and when required
by the Note and this Agreement; and (iii) it will not fail to remove (or directs its transfer agent not to remove or impairs, delays,
and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof)
on any certificate for any Conversion Shares issued to the Buyer upon conversion of or otherwise pursuant to the Note as and when required
by the Note and/or this Agreement. If the Buyer provides the Company and the Company’s transfer, at the cost of the Buyer, with
an opinion of counsel in form, substance and scope customary for opinions in comparable transactions, to the effect that a public sale
or transfer of such Securities may be made without registration under the 1933 Act, the Company shall permit the transfer, and, in the
case of the Conversion Shares, promptly instruct its transfer agent to issue one or more certificates, free from restrictive legend,
in such name and in such denominations as specified by the Buyer. The Company acknowledges that a breach by it of its obligations hereunder
will cause irreparable harm to the Buyer, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the
Company acknowledges that the remedy at law for a breach of its obligations under this Section 5 may be inadequate and agrees, in the
event of a breach or threatened breach by the Company of the provisions of this Section, that the Buyer shall be entitled, in addition
to all other available remedies, to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing
economic loss and without any bond or other security being required.

 

6.
Conditions to the Company’s Obligation to Sell. The obligation of the Company hereunder to issue and sell the Securities
to the Buyer at the Closing is subject to the satisfaction, at or before the Closing Date of each of the following conditions thereto,
provided that these conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion:

 

a.
The Buyer shall have executed this Agreement and delivered the same to the Company.

 

b.
The Buyer shall have delivered the Purchase Price in accordance with Section 1(b) above.

 

c.
The representations and warranties of the Buyer shall be true and correct in all material respects as of the date when made and as of
the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date), and the Buyer
shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Buyer at or prior to the Closing Date.

 

    	7

    	 

    

 

d.
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

7.
Conditions to The Buyer’s Obligation to Purchase. The obligation of the Buyer hereunder to purchase the Securities at the
Closing is subject to the satisfaction, at or before the Closing Date of each of the following conditions, provided that these conditions
are for the Buyer’s sole benefit and may be waived by the Buyer at any time in its sole discretion:

 

a.
The Company shall have executed this Agreement and delivered the same to the Buyer.

 

b.
The Company shall have delivered to the Buyer the duly executed Note, in accordance with Section 1(b) above.

 

c.
The Irrevocable Transfer Agent Instructions, in form and substance satisfactory to the Buyer, shall have been delivered to and acknowledged
in writing by the Company’s Transfer Agent.

 

d.
The representations and warranties of the Company shall be true and correct in all material respects as of the date when made and as
of the Closing Date as though made at such time (except for representations and warranties that speak as of a specific date) and the
Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date. The Buyer shall have received
a certificate or certificates, executed by the chief executive officer of the Company, dated as of the Closing Date, to the foregoing
effect and as to such other matters as may be reasonably requested by the Buyer including, but not limited to certificates with respect
to the Board of Directors’ resolutions relating to the transactions contemplated hereby.

 

e.
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

    	8

    	 

    

 

f.
No event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not limited
to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its 1934 Act reporting obligations.

 

g.
The trading of the Common Stock on such exchange or electronic quotation system shall not have been suspended by the SEC or an exchange
or electronic quotation system.

 

8.
Governing Law; Miscellaneous.

 

a.
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without
regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Agreement shall be brought only in the state courts of New York or in the federal courts located in the state and county of Nassau.
The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and
shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The Company and Buyer
waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and
costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith
and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable
under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably
waives personal service of process and consents to process being served in any suit, action or proceeding in connection with this Agreement,
the Note, or any related document or agreement by mailing a copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any
right to serve process in any other manner permitted by law.

 

b.
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of
which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party.

 

c.
Headings. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation
of, this Agreement.

 

d.
Severability. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule
of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to
conform with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision hereof.

 

    	9

    	 

    

 

e.
Entire Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor
the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may
be waived or amended other than by an instrument in writing signed by the majority in interest of the Buyer.

 

f.
Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be
in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified,
return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified most
recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a)
upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address
or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the
first business day following such delivery (if delivered other than on a business day during normal business hours where such notice
is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed
to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be
as set forth in the heading of this Agreement with a copy by fax only to (which copy shall not constitute notice) to Naidich Wurman LLP,
111 Great Neck Road, Suite 214, Great Neck, NY 11021, Attn: Allison Naidich, facsimile: 516-466-3555, e-mail: allison@nwlaw.com.
Each party shall provide notice to the other party of any change in address.

 

g.
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
assigns. Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder without the prior written
consent of the other. Notwithstanding the foregoing, the Buyer may assign its rights hereunder to any person that purchases Securities
in a private transaction from the Buyer or to any of its “affiliates,” as that term is defined under the 1934 Act, without
the consent of the Company.

 

h.
Survival. The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall
survive the closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The Company agrees
to indemnify and hold harmless the Buyer and all their officers, directors, employees and agents for loss or damage arising as a result
of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants set forth in this
Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.

 

    	10

    	 

    

 

i.
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

j.
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

k.
Remedies. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by
vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law
for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach by
the Company of the provisions of this Agreement, that the Buyer shall be entitled, in addition to all other available remedies at law
or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any
breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing economic loss
and without any bond or other security being required.

 

[THE
REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

 

    	11

    	 

    

 

IN
WITNESS WHEREOF, the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first above written.

 

CLEAN
ENERGY TECHNOLOGIES, INC.

 

	By:	 	 
		Kambiz
    Mahdi	 
	 	Chief
    Executive Officer	 

 

GENEVA
ROTH REMARK HOLDINGS INC.

 

	By:	 	 
	 	Curt
    Kramer	 
	 	President	 

 

	Aggregate Principal Amount of Note:	 	$	142,720.00	 
	Original Issue Discount	 	$	14,720.00	 
	Aggregate Purchase Price:	 	$	128,000.00	 

 

    	12Exhibit 10.6

 

MANAGEMENT SERVICES AGREEMENT

 

This Management Services Agreement
(this “Agreement”) dated as of [____________], is between [____________] (the “Professional Company”),
and EBS Enterprises, LLC, a Delaware limited liability company (the “Management Company”). The Professional Company
and the Management Company are collectively referred to herein as the “Parties”.

 

RECITALS

 

A.            The
Professional Company is engaged in the provision of professional medical services (the “Practice”) at one or more
locations in the State of [____________], and the Professional Company’s professional clinical staff hold all licenses and permits
necessary to engage in the Practice in the State of [____________].

 

B.             The
Professional Company desires to engage the Management Company exclusively to provide and arrange non-professional management, administrative,
advisory, and back-office services to support the Professional Company’s clinical operations.

 

C.             Capitalized terms used but not otherwise defined in this Agreement will have the respective meanings set forth in Article VIII.

 

AGREEMENT

 

The Parties hereby agree as
follows:

 

Article
I

ENGAGEMENT AND AUTHORITY

 

1.1           Engagement of the Management Company. On the terms of this Agreement, the Professional Company hereby engages the Management
Company, and the Management Company hereby accepts engagement by the Professional Company, exclusively to provide and/or arrange for
the provision of the Management Services described in Article II to the Professional Company. The Professional Company expressly
acknowledges that the Management Company may delegate to or subcontract with third parties for the performance of certain Management
Services. No provision of this Agreement will or is intended to limit the right, authority or ability of the Management Company or its
affiliates to contract with or provide services to any other practice, physician or other Person.

 

1.2           Relationship of Parties. In performing their respective duties and obligations under this Agreement, the Parties are independent
contractors. The Parties will not be deemed to be joint venturers, partners or employees of each other and no provision in this Agreement
or any related agreement creates or is intended to create or result in any employment, franchise, partnership or joint venture relationship
between the Parties. The Parties shall not treat, for federal or applicable state, local or non-U.S. income tax purposes, this agreement
or any related agreements or arrangements as giving rise to a partnership between the Professional Company and/or one or more holders
of equity interests in the Professional Company, on the one hand, and the Management Company or one or more direct or indirect holders
of equity interests in the Management Company, on the other hand.

 

1.3           Conduct
of Professional Practice. The Professional Company will solely and exclusively control the provision of professional clinical services,
and the Management Company will neither have nor exercise any control or discretion over the methods by which the Clinical Professionals
render professional clinical services nor their independent professional judgment. Nothing in this Agreement will be construed to alter
or otherwise affect the legal, ethical, or professional relationships between and among the Professional Company, the Clinical Professionals
and their patients, nor does anything in this Agreement abrogate any right, privilege, or obligation arising from or related to the physician-patient
relationship. If any Management Service or other act required or requested to be performed by the Management Company under this Agreement
is construed or deemed to constitute the practice of medicine under, or would otherwise violate, applicable Law, such requirement or
request will be deemed to be waived and inapplicable by the Parties and will not be required of or performed by the Management Company.

 

     

     

    

 

1.4           Facilities. The Professional Company conducts the Practice at the location(s) identified on Exhibit A to this
Agreement (each a “Facility” and collectively, the “Facilities”), as such Exhibit is amended from
time to time by the Management Company to reflect changes in such locations. If the Professional Company intends to directly or indirectly
add any location for the Practice, then (i) the Professional Company will give reasonable (but no less than ninety (90) days) prior written
notice thereof to the Management Company and provide the Management Company with information regarding the location and proposed action
and timing thereof, and other information regarding such location as reasonably requested by the Management Company, (ii) unless the Management
Company gives notice to the contrary to the Professional Company, if and when added, such location will be deemed automatically to be
included within the definition of the Practice and Facilities and the scope of the Management Company’s engagement under this Agreement,
and (iii) Exhibit A will be deemed automatically amended to reflect the addition, deletion or relocation, as applicable, of such
Facility; provided that the Management Company may update and amend Exhibit A from time to time as appropriate to reflect changes
in the Facilities’ locations after the date hereof.

 

Article
II

MANAGEMENT SERVICES

 

2.1           General Authority. Except to the extent prohibited by applicable Law regarding the practice of medicine and subject to the
limitations set forth in this Agreement, the Management Company will provide or arrange for the provision of non-professional management,
business, administrative, advisory and back-office services to support the Professional Company’s clinical operations, including
the services set forth in this Article II (the “Management Services”), and the Management Company will be the
Professional Company’s exclusive provider of Management Services. The foregoing notwithstanding, the Management Company will not
provide any service that constitutes the practice of medicine under applicable Law or the provision of professional medical services in
violation of applicable Law. The Professional Company expressly authorizes the Management Company to perform the Management Services in
the manner that the Management Company deems reasonably appropriate to meet the day-to-day business needs of the Practice, including the
performance of certain business office functions at locations other than the Facilities.

 

    - 2 -

     

    

 

2.2           Billing, Collection and Disbursements.

 

(a)            Authorization.
The Professional Company hereby authorizes the Management Company (and its subcontractors and designees) to bill and collect for
all clinical services rendered by or on behalf of the Professional Company and all other amounts payable to the Professional Company,
including all amounts due for all services furnished by or under the supervision of the Clinical Professionals acting for or on behalf
of the Professional Company. To facilitate such billing and collection services, the Professional Company will cause the Clinical Professionals
to endorse and deliver to the Professional Company promptly all payments received by them in respect of any services rendered and products
sold by or on behalf of the Professional Company. The Professional Company, in accordance with applicable Law, hereby grants to the Management
Company an exclusive, special power of attorney and appoints the Management Company as an exclusive and lawful agent and attorney-in-fact
to:

 

(i)               submit
bills and claims for reimbursement to patients and Third-Party Payors, in the Professional Company’s name and on the Professional
Company’s behalf, for the payment, reimbursement, or indemnification of services rendered and products provided to patients by
or on behalf of the Professional Company;

 

(ii)              collect
all receivables for services rendered and products provided to the Professional Company’s patients by or on behalf of the Professional
Company and administer the deposit of all collected amounts into Revenue Accounts;

 

(iii)            
collect all cash payments to the Professional Company (including patient co-payments, co-insurance, and deductibles and accounts
receivable) for deposit into a Revenue Account;

 

(iv)             make
demand with respect to, settle, compromise, and adjust any claims and to coordinate with collections agencies to commence any suit, action
or proceeding to collect upon such claims;

 

(v)             take
possession of and endorse, in the name of the Professional Company or any of the Clinical Professionals, any negotiable instrument received
as payment for any services rendered or products provided by or on behalf of the Professional Company;

 

(vi)            transfer
from the Revenue Accounts and Operating Accounts, to an account designated by the Management Company amounts sufficient to pay all outstanding
Management Fees, expense reimbursements, and other amounts due to the Management Company under this Agreement or the Deficit Funding
Loan Agreement; and

 

(vii)           sign
negotiable instruments on the Professional Company’s behalf and to make withdrawals from the Revenue Accounts and the Operating
Account to pay the Professional Company’s expenses, including outstanding Management Fees, expense reimbursements, and other amounts
due to the Management Company or its Affiliates under this Agreement, the Deficit Funding Loan Agreement or otherwise, and as otherwise
requested by the Professional Company.

 

(b)           Bank
Documentation. Promptly upon the Management Company’s request, the Professional Company will execute and deliver to the Management
Company for further delivery to any financial institution at which any Operating Account or Revenue Account is maintained, such additional
documents and instruments as may be necessary to evidence the power of attorney granted to the Management Company by the Professional
Company pursuant to Section 2.2(a). So long as the Management Company has power of attorney pursuant to Section 2.2(a),
the Professional Company will not take any action that interferes with the transfer of funds to the Operating Accounts from the Revenue
Accounts, nor will the Professional Company or its agents remove, withdraw, or authorize the removal or withdrawal of any funds from
the Revenue Accounts for any purpose except to accomplish the transfer of funds described in Section 2.2(a)(vi) and Section
2.2(a)(vii).

 

(c)           Disbursements. The Management Company will disburse for the benefit of the Professional Company payments of expenses, fees
and other amounts payable by on behalf of the Professional Company with respect to the Practice, if and to the extent the Professional
Company makes funds available to the Management Company therefor (including through the Deficit Funding Loan Agreement). The Professional
Company expressly authorizes the Management Company to make payment to itself or its Affiliates of any amount due to it or any of them
by the Professional Company under this Agreement, the Deficit Funding Loan Agreement or otherwise.

 

(d)           Power
of Attorney. The power of attorney granted under this Section 2.2 expires on the last calendar day of the Term; provided
that the power of attorney will continue in effect until the first (1st) anniversary of the end of the Term for purposes of submitting
claims for and collecting receivables arising from services rendered and products provided by or on behalf of the Professional Company
before the end of the Term.

 

    - 3 -

     

    

 

2.3           Accounts.

 

(a)           Professional
Company Accounts. The Professional Company hereby authorizes the Management Company or its representatives to establish, in the Professional
Company’s name and/or for the Professional Company’s benefit, certain bank accounts, including one (1) or more designated
herein as the “Revenue Account(s)” and one or more designated herein as the “Operating Account(s)”.
To the extent required by applicable Law, each Revenue Account will be in the Professional Company’s name, and the Professional
Company will have control over each Revenue Account. To facilitate the provision by the Management Company of revenue cycle management,
disbursement and other Management Services under this Agreement for the benefit of the Professional Company, each Operating Account will
be in the Management Company’s name.

 

(b)           Revenue
Accounts. All payments due in respect of services rendered and products provided by or on behalf of the Professional Company, and
any other amounts payable to the Professional Company, will be directed to the Revenue Accounts. The Professional Company will enter
into an agreement with a financial institution chosen by the Parties to (i) establish and service the Revenue Accounts subject to the
requirements of this Agreement (including the power of attorney granted under Section 2.2) and (ii) sweep all funds from the Revenue
Accounts into the Operating Accounts on a daily basis. Except in accordance with Section 5.2(b), any modification or revocation
of such authorization and instructions by the Professional Company without the Management Company’s prior written consent will
be in material breach of this Agreement. Except to the extent prohibited by applicable Law, the Professional Company, the Management
Company, and the financial institution maintaining the Revenue Accounts will also enter into a deposit account control agreement pursuant
to which such financial institution agrees to follow the Management Company’s instructions with respect to the Revenue Accounts
without requiring the Professional Company’s further consent.

 

(c)           Operating
Accounts. The Management Company will use the Operating Accounts to receive funds from the Revenue Accounts and pay Professional
Company expenses, amounts due under this Agreement, the Deficit Funding Loan Agreement or otherwise, and such other reimbursable expenses
as the Management Company may pay on the Professional Company’s behalf. Such persons as the Management Company may designate from
time to time will be authorized signatories on the Operating Accounts (“Authorized Signatories”). Except in connection
with a termination of this Agreement in accordance with Section 5.2(b), any modification or revocation of such authorization and
instructions by the Professional Company without the Management Company’s prior written consent will be in material breach of this
Agreement.

 

(d)           Payroll Accounts. The Management Company may, for the benefit of the Professional Company, transfer funds from the Operating
Accounts to applicable payroll accounts for purposes of funding the Professional Company’s payroll needs.

 

(e)            Accounts
Generally. Should the Professional Company, in consultation with the Management Company, decide to open any new bank or other account,
such account will be designated by the Management Company as a Revenue Account and subject to the corresponding requirements of Section
2.3(b). To facilitate the provision by Management Company of revenue cycle management, disbursement and other Management Services
under this Agreement for the benefit of the Professional Company, the Professional Company will deposit and hold all Professional Company
funds in a Revenue Account, subject to the transfer of such funds to the Operating Accounts in accordance with Section 2.3(b).

 

    - 4 -

     

    

 

2.4           Intellectual
Property. The Management Company will permit the Professional Company to use, on a limited, non-exclusive, revocable and non-transferable
basis, the following intellectual property assets (the “Intellectual Property”) during the Term solely in connection
with the Practice and the Management Company’s provision of the Management Services:

 

(a)           the Management Company’s applicable software systems and programs, as such exist and are replaced or updated from time to
time, and

 

(b)           applicable logos, trademarks, trade names, service marks, manuals and proprietary documentation developed by or for or used by
the Management Company in the provision of the Management Services and support for the Professional Company’s clinical operations.

 

All proprietary rights, ownership,
and goodwill in the Intellectual Property will inure and belong to the Management Company. Neither the license granted under this Section
2.4 nor the use by the Professional Company and its agents of the Intellectual Property creates any interest or right, express or
implied, in the Intellectual Property with respect to the Professional Company beyond such limited license and right to use. The Professional
Company hereby covenants not to assert any claim to any Intellectual Property and will cooperate fully with the Management Company in
protecting all rights and interests of the Management Company and its Affiliates in and to the Intellectual Property. The Professional
Company will not use or permit the use any of the Intellectual Property except in connection with the Practice during the Term nor in
any manner that may contravene applicable Law or impair the validity or enforceability of any Intellectual Property. Concurrently with
the execution and delivery of this Agreement, the Professional Company will enter into a separate Intellectual Property Use Agreement
with the Management Company with respect to the Intellectual Property.

 

2.5           Facility
Space. The Management Company will provide, lease, sublease or otherwise arrange for office space for the Facilities, and make such
space available to the Professional Company for use in the provision of Practice Services by the Professional Company, subject to the
terms and conditions of the applicable lease or sublease, for the lesser of the term of this Agreement or the term of the applicable
lease or sublease. The Management Company will provide or arrange for telephone, utilities, Internet service, janitorial services and
repairs reasonably required for each Facility.

 

2.6           Non-Medical
Equipment, Furniture and Furnishings. The Management Company will provide or arrange for information technology, telephones, computers,
software, office equipment and other non-medical business equipment, furniture and furnishings for the Practice. Such non-medical business
equipment, furniture and furnishings, including replacements thereof or additions thereto, will be and remain (as between the parties
hereto) the sole property of the Management Company.

 

2.7           Medical Equipment and Instruments. The Management Company will provide or arrange for medical equipment and instruments for
the Practice. Such equipment and instruments, including replacements thereof or additions thereto, will be and will remain the sole property
(as between the Parties) of the Management Company. The Management Company will use reasonable efforts to arrange for such medical equipment
and instruments to be maintained in good working order and repair.

 

2.8           Supplies.
The Management Company will provide or arrange for the provision of office and clinical supplies for the Practice.

 

2.9           Non-Clinical
and Technical Personnel. The Management Company will provide or arrange for clerical, reception, administrative and other
personnel (other than Clinical Professionals) for the Practice. The Management Company will be responsible for recruiting, training,
supervising, hiring and firing such personnel; provided, however, that, to the extent required by applicable Law or
Third-Party Payors, the Professional Company and its Clinical Professionals will maintain and be responsible for the training and
supervision of such personnel.

 

    - 5 -

     

    

 

2.10         Assistance
in Recruitment of Clinical Professionals. The Management Company will assist the Professional Company in recruiting potential Clinical
Professionals to provide professional services on behalf of the Professional Company, subject to Section 3.2, including carrying
out administrative functions such as advertising for and identifying potential candidates, checking credentials and arranging and scheduling
interviews.

 

2.11         Marketing,
Advertising and Public Relations. Subject to any limitation of applicable Law, the Management Company will advise and assist the
Professional Company with, marketing, advertising and public relations services for the Practice.

 

2.12         Bookkeeping and Accounting Services. The Management Company will provide or arrange for the provision to the Professional Company
of bookkeeping and accounting services for the Practice, including maintaining business records, implementing accounting procedures and
preparing financial and management reports.

 

2.13         Human Resources Services. The Management Company will provide or arrange for payroll and other human resources services for
the Practice. The Professional Company will provide the Management Company in a timely manner with all complete and accurate information
and documentation necessary for the Management Company to provide or arrange for payroll services hereunder.

 

2.14         Compliance.
The Management Company will advise and assist the Professional Company in taking actions reasonably necessary to help ensure that the
operations of the Practice comply with applicable Law.

 

2.15         Practice
Licenses, Registrations, Registrations and Accreditations. The Management Company will advise and assist the Professional Company
in obtaining and maintaining certifications, accreditations and licenses, registrations, permits and other government authorizations
for the Practice.

 

2.16         Contract
Negotiation. To the extent permitted by applicable Law, the Management Company will advise and assist in the negotiation and administration
of, on the Professional Company’s behalf, payor and other contracts, agreements and arrangements for the Practice.

 

2.17         Information
Management and Technology Services. The Management Company will provide or arrange for information management and technology services
for the Practice, including technology for patient scheduling and the storage and maintenance of files and records relating to the operation
of the Practice.

 

2.18         Strategic
Planning and Assistance. The Management Company will provide advice and assistance in strategic planning with respect to the Professional
Company and the Practice.

 

2.19        
Insurance. The Management Company will provide advice and assistance in procuring and continuing insurance coverages for the
Practice.

 

2.20         Professional Advisors. The Management Company will assist and advise the Professional Company in obtaining legal, accounting
and similar professional services for the Practice.

 

    - 6 -

     

    

 

2.21         Services the Management Company May Not Provide. The Management Company will not provide any of the following services to the
Professional Company:

 

(a)            assuming responsibility for the care of patients;

 

(b)           engaging
in any other activity that constitutes the practice of medicine under applicable Law or that would require the Management Company or
its equityholders to have professional licensure under applicable Law regarding the practice of medicine; or

 

(c)            providing the Professional Company or its equityholder(s) with any unlawful inducement or remuneration in exchange for recommending
to patients, or referring patients for, any services.

 

Article
III

GENERAL OBLIGATIONS

 

3.1           Duty
to Cooperate. The Parties acknowledge that cooperation by the Professional Company and its equityholders is critical to the performance
of the Management Company’s duties and obligations under this Agreement. Accordingly, the Professional Company and its equityholders
shall cooperate with the Management Company in, and will not prevent the Management Company from, providing or causing to be provided
Management Services in accordance with this Agreement, and the Professional Company will, from time to time, execute and deliver any
further documents, instruments and other assurances, and will take any other action consistent with the terms of this Agreement and applicable
Law, that may reasonably be requested by the Management Company for purposes of effectuating this Agreement.

 

3.2           Clinical
Professionals. The Professional Company will employ or engage all Clinical Professionals necessary to conduct, manage, and operate
in a proper and efficient manner the Practice at the Facilities, and is responsible for employing or engaging, scheduling and credentialing,
a sufficient number of Clinical Professionals to assure adequate clinical staffing for the Practice and Facilities. The Professional
Company will also be responsible for all compensation, benefits, taxes and contributions with respect to Clinical Professionals, and
will ensure that each Clinical Professional maintains (i) an unrestricted license to practice medicine or other applicable profession
in the state or jurisdiction in which such Clinical Professional provides professional services on behalf of the Professional Company,
and other licenses, permits, certifications, registrations or other authorizations as may be required for such Clinical Professional’s
performance of such services, (ii) his or her professional skills through requisite continuing education and training, and (iii) eligibility
for insurance under the professional liability policy or policies carried by or on behalf of the Professional Company. The Professional
Company will further be responsible for ensuring that Clinical Professionals perform Practice Services in accordance with applicable
Law and prevailing standards of care.

 

3.3           Business
Associate Provisions. The Parties acknowledge and agree that the Professional Company is a “covered entity” (as
defined in HIPAA) and the Management Company is a “business associate” (as defined under HIPAA) of the Professional
Company when the Management Company provides services to the Professional Company involving “protected health information”
(as defined under HIPAA) pursuant to this Agreement. Concurrently herewith, the Management Company and the Professional Company are entering
into a Business Associate Agreement in substantially the form and substance of Exhibit B.

 

    - 7 -

     

    

 

3.4           Other
Responsibilities. The Professional Company will be responsible for:

 

(a)            (i)
implementing and maintaining utilization review and quality assurance guidelines (consistent with guidelines imposed by applicable
third parties), (ii) supervising and ensuring each Clinical Professional’s submission to the Professional Company of complete,
accurate and timely medical records, patient charts and documentation for coding and billing services provided in the Practice, in
compliance with applicable Law and Third-Party Payor requirements, (iii) supervising the taking of corrective action by Clinical
Professionals when Clinical Professionals do not satisfy applicable guidelines, standards, policies, procedures or directives, (iv)
credentialing of Clinical Professionals for the performance of professional services and specific procedures, and ensuring that each
Clinical Professional procures and maintains all provider numbers and other credentials necessary to obtain payment or reimbursement
for professional services, (v) handling impaired Clinical Professionals, and (vi) overseeing, developing, maintaining and
implementing policies of a purely clinical nature (including medical records documentation, clinical communications with patients,
and the determination of resources to be used for particular patients); and

 

(b)           ensuring that (i) it prepares and files with the appropriate governmental authority all applicable annual reports and similar documentation,
and (ii) that it and the Facilities and Clinical Professionals have all licenses, permits, certificates, registrations, certifications
and authorizations as are necessary or appropriate to operate the Practice and offer professional services under applicable Law.

 

3.5           Billing Information. The Professional Company will promptly provide the Management Company with all billing information requested
by the Management Company to enable the Management Company or its subcontractor or other designee to bill and collect fees, charges and
reimbursements on behalf of the Professional Company. The Professional Company will procure any consents to assignments and other approvals
and take any other action reasonably necessary to enable the Management Company or its subcontractor or other designee to obtain payment
or reimbursement from Third-Party Payors and/or patients.

 

3.6           Notice
of Certain Events. The Professional Company will give immediate written notice, together with all relevant documentation and a summary
of relevant facts and circumstances, to the Management Company of any breach or alleged breach by the Professional Company of HIPAA or
other laws regulating the privacy and/or security of individually identifiable health information or any disciplinary, malpractice, enforcement,
revocation or other proceedings, inquiries, subpoenas, civil investigative demands, investigations or other actions initiated against
or involving the Professional Company or any Clinical Professionals. In addition, if (during the Term or thereafter) the Professional
Company receives notice of, or a request to disclose books, documents or records for, an audit, investigation or other review or any
action by any Third-Party Payor or governmental authority with respect to this Agreement or any billing, reimbursement, payment, coding
or provision of services or products that occurred during the Term, the Professional Company will promptly notify the Management Company
in writing of the nature and scope thereof and will make available to the Management Company, upon request, all such books, documents
or records.

 

3.7           Use of Facility Locations and Equipment. The Professional Company will not use any Facility, office space, equipment, goods,
supplies, software, or services provided pursuant to this Agreement or provided pursuant to any lease, sublease or license by the Management
Company, for any purpose other than the provision of professional services in the Practice. The Professional Company will comply with
all applicable Law and contractual requirements governing and regulating the use of such Facilities, office space, equipment, goods, supplies,
software and services.

 

3.8           Regulatory Matters.

 

(a)            The Professional Company and the Clinical Professionals are free, in their sole discretion, to exercise their professional clinical
judgment in the course of treating patients, and nothing in this Agreement permits the Management Company to control or impermissibly
influence the professional clinical judgment of the Professional Company or any Clinical Professional.

 

(b)           The
Professional Company agrees to comply with (i) all Laws applicable to the Professional Company and all Orders by which the
Professional Company is bound or to which the Professional Company is subject (including Laws and Orders relating to the practice of
medicine, institutional and professional licensure, pharmacology and the securing, administering, and dispensing of drugs, devices,
medicines, and controlled substances, medical documentation, medical record retention, laboratory services, unprofessional conduct,
fee-splitting, referrals, billing and submission of false or fraudulent claims, claims processing, quality, safety, medical
necessity, medical privacy and security, patient confidentiality and informed consent, and the hiring of employees or acquisition of
services or supplies from Persons excluded from participation in any Federal Health Care Program) and (ii) the requirements of any
insurance company insuring the Professional Company or the Management Company against liability for injury or accident in or on the
premises of the Professional Company or the Practice.

 

    - 8 -

     

    

 

3.9           Books
and Records. The Professional Company will retain and provide the Management Company with full and unrestricted access to its books
and records (including work papers in the possession of its accountants) with respect to all transactions and the Professional Company’s
financial condition, assets, liabilities, operations and cash flows.

 

Article
IV

COMPENSATION OF THE MANAGEMENT COMPANY AND DEFICIT FUNDING

 

4.1           Management Fee. The Professional Company will pay the Management Company the fee set forth in Exhibit C (collectively,
the “Management Fee”) in consideration of the Management Services rendered by the Management Company. To the extent
that any of the Management Services are subject to any applicable sales and use taxes, the Professional Company agrees to pay in addition
to the payment of the Management Fees, the applicable sales and use taxes owing in respect of such Management Services.

 

(a)           The
Parties have determined the Management Fee to be equal to the fair market value of the Management Services, without consideration of
the proximity of the Professional Company to any referral sources or the volume or value of any referrals from the Management Company
or any of its Affiliates to the Professional Company or from the Professional Company to the Management Company or any of its Affiliates,
that is reimbursed under any government or private health care payment or insurance program or other payor. The Management Fee is not,
and is not intended to constitute, an illegal fee-splitting or impermissible profit-sharing arrangement in violation of applicable Law.

 

(b)           Payment of the Management Fee is not conditioned upon a requirement that the Professional Company make referrals to, be in a position
to make or influence referrals to, or otherwise generate business for the Management Company or any of its Affiliates or a requirement
that the Management Company or any of its Affiliates make referrals to, be in a position to make or influence referrals to, or otherwise
generate business for the Professional Company. The Management Fee does not include any impermissible discount, rebate, kickback, or other
reduction in charge.

 

(c)            Remittances to the Professional Company of monies collected will be made net of that portion of the Management Fee then due and
owing to the Management Company pursuant to this Agreement. The Professional Company expressly authorizes the Management Company to make
withdrawals or payments to itself from time to time of the Management Fee and any other amounts due or payable to the Management Company
as the Management Fee or such other amounts accrue or become due or payable, from any funds made available by or held on behalf of the
Professional Company or otherwise, without any notice to or further authorization from the Professional Company. The Professional Company
will not be entitled to set-off or reduction in the Management Fee or other amounts because of a breach or default under this Agreement
by the Management Company or otherwise.

 

    - 9 -

     

    

 

4.2           Expense
Reimbursement. In addition to the Management Fee, the Professional Company will reimburse the Management Company as incurred for
all fees, costs and expenses incurred by the Management Company for or on behalf of the Professional Company in connection with the
provision of the Management Services, including (i) costs and expenses relating to the acquisition, lease, provision, maintenance,
refurbishment and replacement of clinical office locations, equipment, consumables and disposables, (ii) salaries, wages,
compensation, bonuses and benefits, of employees and independent contractors of the Management Company providing or arranging for
Management Services to or on behalf of the Professional Company, (iii) costs and expenses incurred by or on behalf of the Management
Company in obtaining or retaining the services of any specialist, consultant, professional or vendor to provide services relating to
the Practice or relating to the Management Company’s duties under this Agreement, (iv) property and intangible taxes assessed
against the equipment, goods and supplies provided or arranged for by the Management Company hereunder, (v) liability and other
insurance, (vi) benefit plans, (vii) a reasonable allocation of the Management Company’s corporate overhead and (viii)
professional dues and license fees, continuing education, and other costs, fees and expenses incurred on behalf of the Professional
Company. Remittances to the Professional Company of monies collected will be made net of amounts for which the Management Company is
then due to reimbursement from the Professional Company pursuant to this Agreement.

 

4.3           Failure
to Pay. The Professional Company’s failure to pay any portion of the Management Fee or reimbursable expenses when due will
be a material breach of this Agreement.

 

4.4           Deficit Funding Loan Agreement. If the Professional Company does not have sufficient cash to pay for its liabilities or financial
obligations (including any portion of the Management Fee or reimbursable expenses owed to the Management Company hereunder), then the
Management Company may, in its sole discretion, loan to the Professional Company upon request funds to enable the Professional Company
to pay its liabilities and meet its financial obligations (“Advances”). Funded Advances will be added to the amounts
owed by the Professional Company to the Management Company pursuant to that certain Deficit Funding Loan Agreement of even date herewith
(“Deficit Funding Loan Agreement”) between the Parties and will bear interest as set forth in the Deficit Funding Loan
Agreement. The Professional Company will repay funded Advances in accordance with the terms of the Deficit Funding Loan Agreement or any
related promissory note.

 

Article
V

TERM AND TERMINATION

 

5.1           Initial Term; Automatic Renewals. The initial term of this Agreement begins on the date of this Agreement and ends on the tenth
(10th) anniversary of the date of this Agreement, subject to earlier termination in accordance with Section 5.2 (the “Initial
Term” and, together with all Renewal Terms, the “Term”). Upon expiration of the Initial Term (unless earlier
terminated in accordance with Section 5.2), this Agreement will automatically renew for successive five (5) year terms (each a
 “Renewal Term”) unless (i) either Party delivers written notice to the other Party of its intent not to renew this
Agreement at least twelve (12) months before the end of the Term or then Renewal Term, as applicable, or (ii) this Agreement is otherwise
terminated in accordance with Section 5.2.

 

5.2           Termination. This Agreement may be terminated during the Term:

 

(a)            by
mutual, signed written agreement of the Parties;

 

(b)            by
the Professional Company with written notice to the Management Company if the Management Company materially breaches this Agreement
and fails to cure such breach within one hundred eighty (180) calendar days after receiving written notice from the Professional
Company describing in reasonable detail the nature of the breach (which written notice must be given within sixty (60) days
following the date on which the Professional Company obtains knowledge of such material breach); provided, that, if
such material breach is not reasonably capable of being cured or remedied within such one hundred eighty (180) day period due to the
inherent nature of the breach, and the Management Company commences such cure within such period and acts diligently to cure such
breach, then the Management Company will have such additional period of time as may be reasonably necessary to effect and complete
such cure or remedy, and the Professional Company may not terminate this Agreement pursuant to this Section 5.2(b) with
respect to such breach during such period or if such breach is cured during such period. If the Parties disagree as to the existence
of a breach which gives rise to termination as provided in this Section 5.2(b) or whether such breach has been cured, then
the Parties will resolve the disagreement in accordance with Section 9.16, and this Agreement will not be terminated pursuant
to this Section 5.2(a) with respect to such material breach or alleged material breach during the period of such dispute
resolution, and the Parties will continue to perform under this Agreement during such period;

 

    - 10 -

     

    

 

(c)            by
the Management Company immediately and without notice if (i) the Professional Company materially breaches this Agreement and fails to
cure such breach within thirty (30) calendar days (ten (10) days with respect to the payment of money) after receiving written notice
from the Management Company describing in reasonable detail the nature of the breach, (ii) the Professional Company admits in writing
its inability to pay its debts generally when due, applies for or consents to the appointment of a trustee, receiver, or liquidator of
all or substantially all of its assets, files a petition in voluntary bankruptcy, or makes an assignment for the benefit of creditors,
or otherwise, voluntarily or involuntarily, takes or suffers action taken under any applicable Law for the benefit of debtors, except
for the filing of a petition in involuntary bankruptcy against the Professional Company that is dismissed within sixty (60) calendar
days thereafter, or (iii) the Professional Company or any of its equityholders is excluded, debarred, terminated or suspended from participation
in any Federal Health Care Program, is indicted for, convicted of or pleads guilty or no contest to any crime punishable by imprisonment
or engages in any other conduct that could reasonably be expected to impair the reputation of the Practice or the Management Company;
and/or

 

(d)           by
the Management Company upon at least thirty (30) days prior written notice to the Professional Company.

 

5.3           Effect of Expiration or Termination.

 

(a)            The expiration or termination of this Agreement in accordance with this Article V will automatically relieve and release
each Party from the executory portion of such Party’s obligations under this Agreement; provided, however, that all obligations
expressly extended beyond the Term by the terms of this Agreement (including this Article V, Article VI, Article VII,
and Article IX) will survive the expiration or termination of this Agreement, and expiration or termination of this Agreement for
any reason will not affect any liability or obligation that has accrued to any party hereto prior to such expiration or termination, and
will not constitute an election of remedies by the Party electing to not renew or terminate this Agreement nor a waiver by any Party of
any right, benefit, remedy or relief to which such Party may be entitled at Law, in equity or under this Agreement.

 

(b)           After the expiration or termination of this Agreement, to effect an orderly wind up of the contractual relationship between the
Parties:

 

(i)               the Professional Company will pay to the Management Company promptly (but in any event within ten (10) calendar days) all Management
Fees earned or accrued under this Agreement through the termination date, reimburse all reimbursable expenses incurred before the termination
date and repay all Advances funded before the termination or expiration date; provided, however, that if the Management Company
terminates this Agreement pursuant to Section 5.2(c) or the Professional Company terminates this Agreement in breach of this Agreement,
then such payment will include the immediate payment of all Management Fees owed to the Management Company for the remainder of the Term;

 

    - 11 -

     

    

 

(ii)              the
Professional Company will immediately vacate each Facility and surrender and deliver each Facility to the Management Company, together
with all improvements, equipment, furnishings, and other assets and property therein provided or made available by Management Company,
in the same order and condition as when received (ordinary wear and tear excepted);

 

(iii)            
the Parties will cooperate in good faith to ensure the appropriate billing and collections for services rendered and products provided
by the Clinical Professionals before the expiration or termination of this Agreement, with all such billings and collections and the use
of proceeds therefrom to be billed, collected, deposited, processed and maintained by the Management Company as specified in Section
2.2 and Section 2.3;

 

(iv)            the
Professional Company will, and will cause its Affiliates, directors, managers, officers, equityholders, employees, agents, successors,
and permitted assigns to, immediately cease using the Intellectual Property and will return to the Management Company all written and
other tangible forms, and destroy, delete or erase all electronic forms, of Confidential Information as required under Section 6.2
promptly (but in any event within ten (10) calendar days) after the expiration or termination of this Agreement; and

 

(v)             the Professional Company will retain and provide the Management Company with full and unrestricted access to its books and records
(including work papers in the possession of its accountants) with respect to all transactions and the Professional Company’s financial
condition, assets, liabilities, operations and cash flows during the Term.

 

(c)           Upon any termination or expiration of this Agreement, subject to applicable Law (including HIPAA), the Professional Company will
provide the Management Company with access, at reasonable times and upon reasonable request, to the patient records of the Professional
Company that are in the Professional Company’s possession until the applicable statute of limitations for any claim that may be
asserted against the Management Company arising from its provision of Management Services during the Term or the clinical operations of
the Professional Company during the Term. To the extent permitted by applicable Law (including HIPAA), the Management Company may copy
and retain such records of the Professional Company and use such copies for its own business purposes.

 

(d)           The
Management Company may, in its sole discretion, contract with any physician, professional entity, or other Person that operates or intends
to operate a medical practice or facility in one or more of the locations or service areas in which the Professional Company is or was
operating, and such Person may solicit and employ or engage any Clinical Professional and may solicit and provide care for and services
to patients treated or formerly treated by or on behalf of the Professional Company (irrespective of any notice requirements or restrictive
covenants with the Professional Company, which shall not apply to any such solicitation, employment, engagement or provision). Upon the
request of any such Person or patient, the Management Company may, on behalf of the Professional Company, transfer to such Person for
treatment purposes copies of the medical records and patient charts of any patient or former patient of the Professional Company who
becomes a patient of such Person; provided, that, to the extent required by HIPAA, the applicable patient shall have authorized
such transfer to such other Person. None of the foregoing actions will be deemed or construed to be tortious or in breach of any provision
of this Agreement or any other agreement between the Parties or the equityholders thereof, nor any agreement between the Professional
Company and any Clinical Professional.

 

    - 12 -

     

    

 

 

Article
VI

RESTRICTIVE COVENANTS

 

6.1              
Restrictive Covenants. In the course of receiving the Management Services, the Professional Company will have access to sensitive
and valuable trade secrets, proprietary information and other confidential information, including management reports, marketing studies,
marketing plans, business plans, financial statements, feasibility studies, financial, accounting and statistical data, price and cost
information, customer lists, employee information, forms, manuals, handbooks, contracts, policies and procedures, internal memoranda,
reports, budgets and other materials, information or records of a proprietary or confidential nature (collectively, “Confidential
Information”) of the Company Group, which constitute valuable business assets of the Company Group, and the use, application,
or disclosure of such Confidential Information will cause substantial and possibly irreparable damage to the business and asset value
of the Company Group. Therefore, as an inducement for the Management Company to enter into this Agreement and to protect the Confidential
Information and other business interests of the Company Group, the Professional Company agrees to be bound by the restrictive covenants
contained in this Article VI.

 

6.2              
Confidentiality.

 

(a)               
During the Term and thereafter, the Professional Company will keep confidential and not disclose to any other Person or use for
its own benefit or the benefit of any other Person the terms of this Agreement and all Confidential Information; provided that
the Professional Company may disclose the terms of this Agreement and Confidential Information (i) to the Professional Company’s
attorneys, accountants, and other advisors who are advising it with respect to this Agreement, but only for legitimate business purposes
related to the negotiation and performance of this Agreement and with a covenant from those Persons to keep such information confidential
in accordance with this Section 6.2(a) and (ii) to the extent that disclosure is required by applicable Law or Order; provided
that as soon as reasonably practicable before such disclosure, the Professional Company gives the Management Company prompt written
notice of such disclosure to enable the Management Company to seek a protective order or otherwise preserve the confidentiality of such
information.

 

(b)               
Promptly after the expiration or termination of this Agreement, the Professional Company will either return to the Management Company
or destroy, delete, or erase (with written certification of such destruction, deletion, or erasure provided to the Management Company
by the Professional Company) all written, electronic, or other tangible forms of Confidential Information. After the expiration or termination
of this Agreement, the Professional Company will not, and will cause its Affiliates, directors, managers, officers, equityholders, employees,
agents, successors, and permitted assigns not to, retain any copies, summaries, analyses, compilations, reports, extracts or other materials
containing or derived from any Confidential Information, except to the extent required by applicable Law. Such return, destruction, deletion,
or erasure notwithstanding, all oral Confidential Information and the information embodied in all written Confidential Information will
continue to be held confidential pursuant to the terms of this Section 6.2.

 

6.3              
Covenant Not to Compete. During the Restricted Period, the Professional Company will not, directly or indirectly, own, manage,
operate, join, control, finance, or participate in the ownership, management, operation, control or financing of, or be connected as
an owner, investor, partner, joint venturer, director, limited liability company manager, employee, independent contractor, consultant,
financing source or other agent of, any Person or enterprise that provides, or is seeking, planning or attempting to provide, any management,
business, administrative, advisory, back-office or other services similar to any of the Management Services anywhere in or with respect
to the Restricted Territory (each, a “Competitor”), or attempt or assist anyone else to do so. Nothing in this Section
6.3 prohibits the Professional Company or the Clinical Professionals from providing professional clinical services.

 

    - 13 -

     

    

 

6.4              
Covenant Not to Solicit. During the Restricted Period, the Professional Company will not, directly or indirectly:

 

(a)               
solicit or induce or attempt to solicit or induce (including by recruiting, interviewing or identifying or targeting as a candidate
for recruitment) any employee, independent contractor, officer, member of the board of directors or equivalent governing body, consultant
or other personnel (whether engaged as an employee or independent contractor) of the Company Group or Supported Practice (excluding the
Professional Company) who is acting in such capacity or acted in such capacity at any time within the twelve (12) month period immediately
preceding the date of such solicitation, inducement or attempt (a “Company Group Associate”) to terminate, restrict
or hinder such Company Group Associate’s association with any Company Group entity or any such Supported Practice interfere in any
way with the relationship between such Company Group Associate and any Company Group entity, or attempt or assist anyone else to do so;
provided, however, that after the termination or expiration of this Agreement, general solicitations published in a journal, newspaper
or other publication or posted on an internet job site and that is not specifically directed toward or targeted at any Company Group Associate,
does not reference any Company Group entity and is not on behalf of any Competitor, will not constitute a breach of the covenants in this
Section 6.4(a);

 

(b)             
hire or otherwise retain or engage (or attempt to hire or otherwise retain or engage) the services of any Company Group Associate
as equityholder, director, limited liability company manager, partner, officer, employee, independent contractor, licensee, consultant,
advisor, agent or in any other capacity, or attempt or assist anyone else to do so; or

 

(c)               
interfere with the relationship between any Company Group entity or Supported Practice (excluding the Professional Company) and
any customer, patient, referral source, Third-Party Payor, supplier, vendor, lessor, lessee, dealer, distributor, licensor, licensee,
equityholder, lender, joint venturer, consultant, agent, or any other Person having a business relationship with any Company Group entity
or such Supported Practice, or attempt or assist anyone else to do so.

 

6.5              
Non-Disparagement. During the Term and thereafter, the Professional Company will not, directly or indirectly, make any disparaging,
derogatory, negative or knowingly false statement about any Company Group entity or Supported Practice or any of their respective directors,
managers, officers, equityholders, employees, agents (including the Management Company Representative), successors, and permitted assigns,
or any of their respective businesses, operations, financial condition, or prospects, except as required by applicable Law or Order or
in the course of filing a charge with a government agency or participating in its investigation.

 

6.6              
Scope of Covenants; Equitable Relief. The Professional Company acknowledges and agrees that (i) the restrictive covenants contained
in this Article VI and the territorial, time, activity, and other limitations set forth herein are commercially reasonable and
do not impose a greater restraint than is necessary to protect the goodwill and legitimate business interests of the Company Group and
its businesses, (ii) any breach of the restrictive covenants in this Article VI will cause irreparable injury to the Company Group
and actual damages may be difficult to ascertain and would be inadequate, (iii) if any breach of any such covenant occurs, then the Management
Company will be entitled to injunctive relief in addition to such other legal and equitable remedies that may be available (without the
requirement to post bond or other security), and (iv) the Professional Company hereby waives the claim or defense that an adequate remedy
at law exists for such a breach.

 

6.7              
 Equitable Tolling. If the Professional Company breaches any covenant in this Article VI, then the duration of
such covenant will be tolled for a period of time equal to the time of such breach.

 

    - 14 -

     

    

 

Article
VII

INDEMNIFICATION AGAINST PROFESSIONAL LIABILITIES

 

7.1              
Indemnification. The Professional Company will indemnify and hold harmless each member of the Company Group and its directors,
managers, officers, equityholders, employees, agents (including the Management Company Representative), successors, and permitted assigns
(collectively, the “Management Company Indemnified Parties”) from and against all losses, liabilities, demands, claims,
actions, or causes of action, regulatory, legislative, or judicial proceedings or investigations, assessments, levies, fines, penalties,
damages, costs and expenses (including reasonable attorneys’, accountants’, investigators’, and experts’ fees
and expenses) incurred in connection with the defense or investigation of any claim sustained or incurred by any Management Company Indemnified
Party arising from or related the provision of professional services or breach of this Agreement by the Professional Company or any of
its personnel (whether employees or independent contractors).

 

7.2              
Cooperation and Settlement. The Professional Company and the Management Company will coordinate the defense and settlement
of actions by any third party in which they are named relating to or arising out of the Practice or the Management Services. To the extent
consistent with insurance policies, the Professional Company will not settle an action in which both are named, unless the Management
Company agrees (in its sole discretion) to the terms and conditions of the settlement.

 

7.3              
Advancement of Expenses. During the pendency of any suit, action or proceeding with respect to which the Management Company
is entitled to indemnification under this Article VII, the Professional Company will pay or reimburse the Management Company for
reasonable defense expenses incurred in advance of final disposition of such suit, action or proceeding. If the Management Company ultimately
is not entitled to indemnification under this Article VII, then the Management Company will promptly repay to the Professional
Company the full amount of all such expenses paid or reimbursed by the Professional Company.

 

7.4              
Other Remedies. The provisions of this Article VII are in addition to, and not in derogation of, any statutory, equitable
or common law remedies that the Management Company may have with respect to this Agreement or the subject matter of this Agreement.

 

7.5              
Survival. The Professional Company’s indemnification obligations under this Article VII will survive the termination
or expiration of this Agreement.

 

Article
VIII

DEFINITIONS

 

“Advances”
is defined in Section 4.4.

 

“Affiliate”
means, with respect to a particular Person, (i) any other Person that, directly or indirectly, controls, is controlled by or is under
common control with such Person, (ii) any of such Person’s spouse, siblings (by law or marriage), ancestors and descendants and
(iii) any trust for the primary benefit of such Person or any of the foregoing. The term “control” means possession, direct
or indirect, of the power to direct or cause the direction of the management and policies of another Person, whether through the ownership
of voting securities or equity interests, by contract or otherwise.

 

“Agreement”
is defined in the preamble to this Agreement.

 

    - 15 -

     

    

 

“Authorized Signatories”
is defined in Section 2.3(c).

 

“Budget”
is defined in Section 4.2.

 

“Business Day”
means a day that is not a Saturday, Sunday, or legal holiday on which banks are authorized or required to be closed in New York, New York.

 

“Clinical Professionals”
means all physicians and non-physician providers of Practice Services and any other Person who may only be employed or contracted by an
entity owned directly or indirectly by one or more Persons licensed to practice medicine under applicable Law.

 

“Company Group”
means the Management Company and its subsidiaries and other Affiliates.

 

“Company Group
Associate” is defined in Section 6.4(a).

 

“Confidential Information”
is defined in Section 6.1.

 

“Deficit Funding
Loan Agreement” is defined in Section 4.4.

 

“Federal Health
Care Program” means any “federal health care program” as defined in 42 U.S.C. § 1320a-7b(f), including
Medicare, state Medicaid programs, state CHIP programs, TRICARE and similar or successor programs with or for the benefit of any government
authority.

 

“HIPAA”
means the Health Insurance Portability and Accountability Act of 1996, P.L. 104-191, as amended, and its implementing regulations (45
C.F.R. parts 160-164).

 

“Initial Term”
is defined in Section 5.1.

 

“Intellectual Property”
is defined in Section 2.4.

 

“Law” means
any federal, state, local, municipal, foreign, international, or multinational constitution, statute, law, rule, regulation, ordinance,
code, principle of common law or treaty.

 

“Management Company”
is defined in the preamble to this Agreement.

 

“Management Company
Indemnified Parties” is defined in Section 7.1.

 

“Management Company
Representative” is defined in Section 3.1.

 

“Management Fee”
is defined in Section 4.1.

 

“Management Services”
is defined in Section2.1(a).

 

“Operating Account”
is defined in Section 2.3(a).

 

“Order” means
any order, injunction, judgment, decree, ruling, assessment, or arbitration award of any government authority or arbitrator.

 

“Parties”
is defined in the preamble to this Agreement.

 

“Person”
means any natural individual, corporation, partnership, limited liability company, joint venture, association, bank, trust company, trust,
or other entity, whether or not legal entities, or any government entity, agency, or political subdivision.

 

    - 16 -

     

    

 

“Practice”
is defined in Recital A.

 

“Facilities”
is defined in Recital A.

 

“Professional Company”
is defined in the preamble to this Agreement.

 

“Renewal Term”
is defined in Section 5.1.

 

“Restricted Period”
means the shorter of (i) the period from the date of this Agreement until the second (2nd) anniversary of the termination or expiration
of this Agreement or (ii) the longest time period after the date of this Agreement that is permitted by applicable Law if two (2) years
after the termination of this Agreement is not permitted.

 

“Restricted Territory”
means (i) each state in which any member of the Company Group then-conducts clinical operations or with respect to which any member of
the Company Group has taken concrete steps to expand its clinical operations (such as through (A) development of a written business plan
or presentation, (B) a corporate resolution to provide or sell services or products or incur capital expenditures or (C) a written letter
of intent or term sheet regarding the provision or sale of such services or products or capital expenditures).

 

“Revenue Account”
is defined in Section 2.3(a).

 

“Supported Practice”
means each Person to which the Management Company or any of its Affiliates provides any non-clinical business, management, administrative,
advisory, or back office services.

 

“Term”
is defined in Section 5.1.

 

“Third-Party Payors”
means all Federal Health Care Programs and all other state or local governmental insurance programs and private, non-governmental insurance
and managed care programs with which the Professional Company contracts to provide services and products or through which the Professional
Company receives reimbursements for services rendered and products provided.

 

Article
IX

GENERAL PROVISIONS

 

9.1            
Practice of Medicine. Nothing in this Agreement will be interpreted as prohibiting the Professional Company or any Clinical
Professional from (a) obtaining or maintaining membership on the medical staff of any hospital or health care provider, (b) obtaining
or maintaining clinical privileges at any hospital or health care provider or (c) referring patients to any hospital or health care provider.

 

9.2              
Force Majeure. Neither Party will be liable for any failure or inability to perform, or delay in performing, such Party’s
obligations under this Agreement if such failure, inability, or delay arises from an extraordinary cause beyond the reasonable control
of the non-performing Party; provided that such Party diligently and in good faith attempts to cure such non-performance as promptly
as practicable.

 

    - 17 -

     

    

 

9.3              
Notices. All notices and other communications required or permitted under this Agreement (a) must be in writing, (b) will be
duly given (i) when delivered personally to the recipient or sent to the recipient by facsimile (with delivery confirmation retained)
or (ii) one (1) Business Day after being sent to the recipient by nationally recognized overnight private carrier (charges prepaid) and
(c) addressed as follows (as applicable):

 

	If to the Professional Company:	If to the Management Company:
	[____________]	
    [____________]

     

    With a copy (which shall not constitute notice) to:

     

    [____________]

     

or to such other respective address as each Party
may designate by notice given in accordance with this Section 9.3.

 

9.4             
Entire Agreement. This Agreement (together with the exhibits and schedules hereto, the License Agreement, the Business Associate
Agreement, the Deficit Funding Loan Agreement and any other agreement(s) entered into by and between the Parties in connection with this
Agreement) constitutes the complete agreement and understanding among the Parties regarding the subject matter of this Agreement and supersedes
any prior understandings, agreements or representations regarding the subject matter of this Agreement.

 

9.5              
Amendments. The Parties may amend this Agreement only pursuant to a written agreement executed by the Parties.

 

9.6              
Non-Waiver. The Parties’ respective rights and remedies under this Agreement are cumulative and not alternative. Neither
the failure nor any delay by any Party in exercising any right, power or privilege under this Agreement will operate as a waiver of such
right, power or privilege, and no single or partial exercise of any such right, power or privilege will preclude any other or further
exercise of such right, power or privilege or the exercise of any other right, power or privilege. No waiver will be effective unless
it is in writing and signed by an authorized representative of the waiving Party. No waiver given will be applicable except in the specific
instance for which it was given. No notice to or demand on a Party will constitute a waiver of any obligation of such Party or the right
of the Party giving such notice or demand to take further action without notice or demand as provided in this Agreement.

 

9.7              
Assignment. The Parties may not assign this Agreement or any rights under this Agreement, or delegate any duties under this
Agreement, without the prior written consent of the Management Company and the Professional Company; provided, however, that the
Management Company may freely assign this Agreement or any rights under this Agreement, or delegate any duties under this Agreement without
the Professional Company’s consent (a) to another Company Group entity, (b) as a collateral assignment to the Management Company’s
lenders or (c) to any Person (i) into which the Management Company merges or consolidates, (ii) acquiring all or substantially all of
the Management Company’s assets, or (iii) acquiring control of the Management Company by equity or membership interest purchase.

 

9.8              
Binding Effect; Benefit. This Agreement will inure to the benefit of and bind the Parties and their respective successors and
permitted assigns. Nothing in this Agreement, express or implied, may be construed to give any Person other than the Parties and their
respective successors and permitted assigns any right, remedy, claim, obligation, or liability arising from or related to this Agreement.
This Agreement and all of its provisions and conditions are for the sole and exclusive benefit of the Parties and their respective successors
and permitted assigns.

 

9.9             Severability.
If any court of competent jurisdiction holds any provision of this Agreement invalid or unenforceable, then the other provisions of
this Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or
degree will remain in full force and effect to the extent not held invalid or unenforceable. If any court of competent jurisdiction
holds the geographic or temporal scope of any restrictive covenant contained in Article VI invalid or unenforceable, then
such restrictive covenant will be construed as a series of parallel restrictive covenants and the geographic or temporal scope of
each such restrictive covenant will be deemed modified (including by application of any “blue pencil” doctrine under
applicable Law) to the minimum extent necessary to render such restrictive covenant valid and enforceable.

 

    - 18 -

     

    

 

9.10          
Changes in Law. If there is a change in any applicable Law or the interpretation or application thereof, or the adoption, enactment,
promulgation, issuance, rendering or interpretation or application of any new applicable Law, any of which adversely affects or are reasonably
likely to adversely affect the manner in which either Party may perform or the manner in which the Management Company is compensated for
its services under this Agreement or which makes or will make this Agreement or the arrangements hereunder unlawful or illegal, or if
either Party provides in good faith to the other Party a written opinion from legal counsel experienced in construing contracts such as
this Agreement that any provision of this Agreement violates or could reasonably be determined to violate such Laws, then the Management
Company will propose a written amendment to or restatement of this Agreement or a new service arrangement or basis for compensation for
the Management Services provided pursuant to this Agreement, the purpose and substance of which will be modification of only such provision
or provisions so that this Agreement, as modified, complies with the applicable Law, interpretation or application, and continues to reflect,
as nearly as possible, the economic arrangements and position of the Parties under this Agreement. If the Parties are unable to resolve
the matter through good faith negotiations within sixty (60) days thereafter, then either Party may initiate the dispute resolution procedures
set forth in Section 9.16 or the Management Company may elect to terminate this Agreement upon at least thirty (30) days prior
written notice to the Professional Company.

 

9.11          
References. The headings of Sections are provided for convenience only and will not affect the construction or interpretation
of this Agreement. Unless otherwise provided, references to “Section(s)” and “Exhibit(s)” refer to the corresponding
section(s) and exhibit(s) of this Agreement. Reference to a statute refers to the statute, any amendments or successor legislation and
all rules and regulations promulgated under or implementing the statute, as in effect at the relevant time. Reference to a contract, instrument
or other document as of a given date means the contract, instrument or other document as amended, supplemented and modified from time
to time through such date.

 

9.12          
Construction. Each Party participated in the negotiation and drafting of this Agreement, assisted by such legal and tax counsel
as it desired, and contributed to its revisions. Any ambiguities with respect to any provision of this Agreement will be construed fairly
as to all Parties and not in favor of or against any Party. All pronouns and any variation thereof will be construed to refer to such
gender and number as the identity of the subject may require. The terms “include” and “including” indicate examples
of a predicate word or clause and not a limitation on that word or clause.

 

9.13          
Governing Law; Venue; Attorneys’ Fees. THIS AGREEMENT IS GOVERNED BY THE LAWS OF THE STATE OF DELAWARE, WITHOUT REGARD
TO CONFLICT OF LAWS PRINCIPLES. Subject to the provisions of Section 9.14 hereof, all actions, suits or other proceedings with
respect to this Agreement will be brought only in a court of competent jurisdiction sitting in the State of Delaware. In any civil action,
arbitration or other proceeding brought to enforce the terms hereof, or to redress a breach of a term hereof, the more prevailing party
will be entitled to payment from the less-prevailing party of its reasonable attorneys’ fees and expenses in addition to any damages
or other relief to which it may become entitled.

 

    - 19 -

     

    

 

9.14           Dispute
Resolution. Except as expressly provided below in this Section 9.14, any dispute, claim or controversy between the
Parties arising out of or relating to this Agreement or any of the other agreements referenced herein or any of the arrangements
contemplated herein or therein, whether arising in contract, tort or by statute or other Law, including but not limited to
controversies or claims that arise out of or relate to this Agreement and any dispute or claim concerning the existence, validity,
enforceability, interpretation, performance, breach or termination of this Agreement or such other agreements or arrangements and
all claims of arbitrability (any of the foregoing, a “Dispute”) will, unless resolved by mutual written agreement
of the Parties, be resolved exclusively as follows:

 

(a)       Upon
the written demand of either Party, the Dispute will be submitted to mediation administered by the American Health Lawyers Association
or its successor (“AHLA”) in accordance with its rules for mediation. Representatives of the Parties with authority
to settle the Dispute will participate in the mediation. The mediator will be selected and appointed in accordance with such AHLA rules,
and the mediation will be conducted in New York, New York. Each Party may be represented by one or more attorneys or other selected representative(s)
of its choice. Each Party will bear and pay equally the fees and expenses of AHLA and the mediator associated with the mediation, and
each such party will bear its own attorneys’ fees, costs and other expenses in connection with the mediation (except as may be otherwise
mutually agreed upon in writing).

 

(b)       If
no amicable resolution or settlement of the Dispute is reached during the mediation process within sixty (60) days after it commences,
then upon the written demand of either Party, the Dispute will be submitted to final and binding arbitration, which will be conducted
expeditiously and completed within one hundred twenty (120) days after being submitted for arbitration. The arbitration will be governed
by the Federal Arbitration Act (9 U.S.C. §§ et seq.). Unless otherwise agreed in writing by the Parties, the arbitration
will be administered by the AHLA and conducted by a single arbitrator in accordance with the AHLA Rules of Procedure for Commercial Arbitration
then in effect. The arbitrator will be selected and appointed in accordance with such AHLA rules, and the arbitration will be conducted
in New York, New York. Each Party may be represented by one or more attorneys or other selected representative(s) of its choice. Each
Party will bear and pay equally the fees and expenses of AHLA and the arbitrator associated with the arbitration, and each such party
will bear its own attorneys’ fees, costs and other expenses in connection with the arbitration, except as may be otherwise awarded
by the arbitrator as contemplated in Section 9.13. The arbitration award will be final and binding, and judgment on it may be entered
by any court of competent jurisdiction. If the arbitrator determines that this Agreement or any part thereof (whether this Agreement itself
or together with the other relationships between or involving the parties to this Agreement) is illegal, invalid, unenforceable, void
or voidable, then the arbitrator will determine and effectuate an equitable modification of this Agreement (including a new arrangement
or basis for compensation to the Management Company pursuant to the Agreement) that complies with applicable Law and that approximates
as closely as possible the economic arrangements and position of the Parties hereunder.

 

(c)       All
privileges under applicable Law, including attorney-client and work-product privileges, will be preserved and protected to the
maximum extent that such privileges would be protected in a federal or state court proceeding applying Delaware law. The arbitration
proceedings and arbitration award will be maintained by the parties as strictly confidential, except as is otherwise required by
court order or as is necessary to confirm, vacate or enforce the award and for disclosure to the respective officers, directors,
managers, employees, equityholders, attorneys, accountants, lenders, acquirers and prospective lenders and acquirers (and advisors
of the foregoing) of the parties hereto. The provisions of this Section 9.14 will survive expiration or other termination of
this Agreement regardless of the cause of such expiration or termination. This Section 9.14 will not preclude the Management
Company from seeking, or a court of competent jurisdiction from granting, a temporary restraining order, preliminary injunction,
injunction, specific performance or other equitable relief to remedy any breach or to enforce applicable terms of this Agreement to
compel mediation or arbitration or upon the occurrence of (i) a breach or threatened breach of this Section 9.14 or any
confidentiality, non-solicitation or other restrictive covenants herein, (ii) eviction of the Professional Company from any Facility
or office space or return of any property, or (iii) any attempted assignment of the Professional Company’s interests in this
Agreement in breach of the provisions of this Agreement.

 

    - 20 -

     

    

 

9.15         Waiver
of Trial by Jury. EACH PARTY HEREBY WAIVES ITS RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY DISPUTE, SUIT, ACTION, ARBITRATION OR
PROCEEDING IN CONNECTION WITH ANY MATTER RELATING TO THIS AGREEMENT.

 

9.16          
Counterparts. The Parties may execute this Agreement in multiple counterparts, each of which will constitute an original and
all of which, when taken together, will constitute one and the same agreement. The Parties may deliver executed signature pages to this
Agreement by facsimile or e-mail transmission. No Party may raise as a defense to the formation or enforceability of this Agreement (and
each Party forever waives any such defense) any argument based on either (a) the use of a facsimile or email transmission to deliver a
signature or (b) the fact that any signature was signed and subsequently transmitted by facsimile or email transmission.

 

9.17          
Enforceability. The Parties have carefully structured this Agreement and the arrangements hereunder to comply with applicable
Law, and have consulted to their satisfaction with their respective legal counsel in connection herewith. Each Party acknowledges and
agrees that this Agreement and such arrangements are valid, legal and enforceable obligations of such Party, and each Party agrees that
it will not make, assert, maintain or initiate, nor cause to be made, asserted, maintained or initiated, any claim, charge, demand, action,
arbitration or proceeding of any type, the basis of which is, in whole or in part, that this Agreement or any other agreement referenced
or contemplated herein or any portion hereof or thereof, or the relationships or arrangements created hereby or thereby, is illegal, invalid
or unenforceable, or that any amount payable to the Management Company under this Agreement is unreasonable or unlawful or does not represent
fair market value for the Management Services and other items provided by the Management Company. If a Party takes any action which is
inconsistent with the preceding sentence, then such Party will pay all losses, damages, costs, fees and expenses (including reasonable
attorneys’ fees) incurred by the other Party, including in defending or responding to such claim, charge, demand, action, arbitration
or proceeding, which payment will be made promptly to such other Party upon its request.

 

9.18          
No Warranties. The Professional Company acknowledges that the Management Company has not made and will not make any express
or implied warranties or representations that the Management Services will result in any amount or level of revenue or profits to the
Professional Company and that THE MANAGEMENT COMPANY MAKES NO WARRANTIES, EXPRESS OR IMPLIED,
HEREUNDER, AND ALL EQUIPMENT, SOFTWARE AND OTHER ASSETS ARE PROVIDED BY THE MANAGEMENT COMPANY “AS IS,” AND ANY AND ALL WARRANTIES,
EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, WITH RESPECT THERETO OR ANY SERVICES PROVIDED HEREUNDER ARE HEREBY WAIVED, INCLUDING ANY WARRANTIES
OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

 

[SIGNATURE PAGE IMMEDIATELY FOLLOWS]

 

    - 21 -

     

    

 

The Parties sign this Agreement as of
the date first written above.

	 	 
	THE PROFESSIONAL COMPANY:	
    [____________]

 

	 	By:	 
	 	 	[____________]

 

	THE MANAGEMENT COMPANY:	
    EBS Enterprises,
LLC, a Delaware limited liability company

     

 

		By:	 
	 	Name:	Aaron Rollins,
    M.D.
	 	Title:	President

 

[Signature Page to Management Services Agreement]

 

     

     

    

 

EXHIBIT A

 

LOCATIONS

 

     

     

    

 

EXHIBIT B

 

BUSINESS ASSOCIATE AGREEMENT

 

     

     

    

 

EXHIBIT C

 

MANAGEMENT FEE

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]